Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WV › MADISON › BOONE MEMORIAL HOSPITAL, INC

BOONE MEMORIAL HOSPITAL, INC

NPI: 1639135221 · MADISON, WV 25130 · Institutional Pharmacy · NPI assigned 04/24/2006

$31.87M
Total Medicaid Paid
528,874
Total Claims
421,557
Beneficiaries
212
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMALCOLM, DOUGLAS (CFO)
NPI Enumeration Date04/24/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 76,924 $4.91M
2019 39,662 $2.53M
2020 95,771 $7.31M
2021 93,369 $5.89M
2022 71,460 $3.89M
2023 88,279 $4.26M
2024 63,409 $3.08M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 16,086 12,617 $2.89M
99284 Emergency department visit for the evaluation and management, high severity 19,447 16,446 $2.69M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 15,796 14,426 $2.54M
80053 Comprehensive metabolic panel 32,907 27,146 $1.52M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,875 2,573 $1.45M
99283 Emergency department visit for the evaluation and management, moderate severity 14,077 12,532 $1.26M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 33,217 25,305 $914K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,533 1,164 $905K
87631 9,488 8,616 $889K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,047 1,836 $805K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3,328 2,965 $802K
70450 Computed tomography, head or brain; without contrast material 3,658 3,246 $765K
84484 13,787 6,721 $606K
36415 Collection of venous blood by venipuncture 46,152 35,162 $511K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 7,716 6,478 $506K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 898 649 $467K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 9,825 7,882 $428K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,491 1,246 $423K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,157 2,131 $368K
81000 20,113 17,315 $361K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5,166 1,090 $331K
80050 General health panel 3,961 3,501 $317K
71275 Computed tomographic angiography, chest, with contrast material 968 867 $305K
96375 Therapeutic injection; each additional sequential IV push 8,197 7,090 $296K
83605 12,905 9,962 $293K
94760 8,018 6,970 $292K
96361 Intravenous infusion, hydration; each additional hour 5,169 4,513 $264K
71045 Radiologic examination, chest; single view 6,873 5,727 $239K
71046 Radiologic examination, chest; 2 views 4,162 3,666 $237K
80061 Lipid panel 6,547 6,142 $235K
83880 4,836 4,059 $230K
87040 6,852 3,649 $230K
82550 8,317 6,869 $220K
82150 7,455 6,450 $218K
72125 Computed tomography, cervical spine; without contrast material 742 674 $217K
83690 7,940 6,815 $216K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,115 3,649 $210K
84443 Thyroid stimulating hormone (TSH) 4,734 4,339 $205K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 531 463 $202K
97014 4,397 860 $186K
87086 Culture, bacterial; quantitative colony count, urine 5,450 4,771 $185K
45380 Colonoscopy, flexible; with biopsy, single or multiple 292 199 $184K
80305 3,979 3,381 $179K
82553 6,550 5,478 $171K
80048 Basic metabolic panel (calcium, ionized) 3,828 2,696 $168K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 2,754 1,356 $160K
71250 766 705 $155K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,420 2,164 $152K
93017 771 687 $141K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,517 2,354 $133K
85610 8,946 7,464 $131K
85651 9,259 8,044 $128K
85730 8,552 7,183 $122K
83036 Hemoglobin; glycosylated (A1C) 5,097 4,791 $115K
73564 1,064 856 $111K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,905 1,704 $110K
87430 6,044 5,282 $109K
74021 1,530 1,406 $106K
87581 2,613 2,340 $102K
87486 2,611 2,338 $102K
81025 2,521 2,170 $101K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,409 885 $89K
72131 270 244 $88K
82803 2,817 2,052 $87K
83735 4,990 3,503 $85K
82962 5,350 1,558 $82K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,034 1,843 $82K
85379 2,656 2,321 $82K
82607 1,739 1,624 $80K
87081 2,157 1,947 $79K
T1015 Clinic visit/encounter, all-inclusive 1,034 799 $77K
76705 Ultrasound, abdominal, real time with image documentation; limited 607 562 $74K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 733 615 $73K
84439 2,348 2,134 $72K
G0378 Hospital observation service, per hour 610 472 $71K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,931 1,692 $71K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 730 649 $68K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 226 191 $67K
43450 233 152 $64K
0202U Oncology (prostate), multianalyte, gene expression profiling 277 258 $61K
93041 2,852 2,541 $48K
74019 489 446 $47K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 590 510 $47K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,272 1,511 $45K
93971 146 136 $41K
73630 915 802 $40K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,048 1,622 $39K
86140 1,061 868 $38K
36600 2,846 2,043 $38K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 353 346 $37K
73030 810 653 $36K
0097U 193 184 $36K
71260 Computed tomography, thorax, diagnostic; with contrast material 103 93 $36K
88342 751 592 $35K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,210 1,047 $34K
84703 880 779 $33K
97161 586 538 $29K
87070 876 742 $29K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 539 370 $28K
77067 Screening mammography, bilateral, including computer-aided detection 319 286 $27K
73610 491 440 $27K
87075 533 455 $26K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,622 1,364 $26K
73130 628 541 $26K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,048 654 $26K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 431 92 $25K
87205 1,111 743 $24K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 776 706 $22K
84480 543 491 $22K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 763 446 $22K
87186 1,166 1,014 $22K
72100 219 202 $21K
96367 853 721 $19K
82140 782 623 $18K
80074 581 492 $18K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 31 28 $17K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 33 26 $16K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 642 485 $16K
84100 1,238 804 $16K
82728 387 349 $15K
96376 652 569 $14K
72110 192 172 $14K
99281 Emergency department visit for the evaluation and management, self-limited or minor 427 381 $14K
73110 201 182 $12K
36000 1,198 1,057 $12K
96368 246 197 $11K
86677 159 128 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 270 222 $11K
J2785 Injection, regadenoson, 0.1 mg 81 64 $10K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 612 539 $10K
J2550 Injection, promethazine hcl, up to 50 mg 231 160 $9K
73503 131 122 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 225 181 $9K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 24 24 $8K
70486 33 30 $8K
93225 31 27 $8K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 113 27 $8K
94729 161 145 $8K
94727 160 144 $8K
86481 106 82 $7K
84145 739 648 $7K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 26 26 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 243 190 $7K
87632 192 180 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 768 678 $6K
93880 29 26 $6K
82043 167 154 $5K
87507 31 25 $5K
94060 160 144 $5K
86780 131 111 $5K
93970 13 12 $4K
87522 Neg quan hep c or qual rna 79 67 $4K
83540 295 266 $4K
80320 251 206 $4K
97035 149 36 $4K
84153 87 84 $4K
87077 456 367 $3K
51702 66 53 $3K
82746 79 69 $3K
84550 126 122 $3K
82272 61 55 $3K
86308 111 100 $3K
80355 116 88 $3K
74022 59 56 $3K
85027 125 105 $3K
73090 39 39 $3K
86592 41 20 $2K
90715 71 58 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 82 72 $2K
76536 13 13 $2K
73590 30 27 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 32 12 $2K
80359 116 88 $2K
80356 116 88 $2K
80362 116 88 $2K
80354 116 88 $2K
84466 13 13 $1K
76641 17 13 $1K
80324 124 88 $1K
72170 15 13 $1K
86038 25 24 $1K
86430 17 17 $1K
12001 13 12 $1K
72072 15 14 $988.99
83550 40 36 $980.30
77066 Tomosynthesis, mammo 13 13 $968.02
29125 26 25 $821.02
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 39 39 $794.90
82565 58 50 $672.35
74018 15 12 $662.48
81002 114 107 $611.32
11102 31 27 $587.98
85007 17 12 $539.99
97150 Therapeutic procedure(s), group (2 or more individuals) 95 24 $506.42
82009 53 46 $433.24
G0659 Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes 135 87 $349.14
99225 15 13 $290.87
86769 13 13 $278.90
J1100 Injection, dexamethasone sodium phosphate, 1 mg 98 88 $183.46
82570 15 14 $160.56
J1885 Injection, ketorolac tromethamine, per 15 mg 104 89 $154.91
J0696 Injection, ceftriaxone sodium, per 250 mg 67 51 $128.56
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only 12 12 $112.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 57 48 $58.14
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 28 25 $52.33
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 15 12 $44.86
J3010 Injection, fentanyl citrate, 0.1 mg 12 12 $21.01
J2270 Injection, morphine sulfate, up to 10 mg 21 15 $13.13
J2919 Injection, methylprednisolone sodium succinate, 5 mg 24 15 $6.17
90792 Psychiatric diagnostic evaluation with medical services 20 16 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 46 42 $0.00
99309 Subsequent nursing facility care, per day, low to moderate complexity 48 40 $0.00